Pharmaceutical and biotech science and business

Visit Pharma's Cutting Edge

My first lesson in technology asset management ends ten years after it began

Posted on April 10, 2008

Symbollon Pharmaceuticals Announces Results of IoGen Phase III Clinical TrialNormally, I wouldn t give a company so small in stature space in these pages, but this news release from tiny Symbollon (market cap pre-announcement circa $10M) stirred some memories for me. You see Iogen, an oral formulation of molecular iodine Symbollon s entire pipeline was also the first drug I was asked to evaluate for possible in-licensing.That was back in 1998, or maybe 1999. I remember feeling expertish.At the time Symbollon was beginning its Phase 2 study of Iogen, but I believe they had some cl...

Original article link


pharma , phase